Patient Care Advancement Cataracts Glaucoma
Philip Tarlow’s inspiration to pursue art was sparked at an early age. He recalls a kindergarten teacher noticing his fascination with construction workers, which ultimately became the subject matter of his creations 30 years later.
Rachel Wittel | 
April 13, 2022
Procedures to alleviate eye pressure associated with blinding diseases such as glaucoma date back over a century. Although glaucoma, a condition that damages the eye’s optic nerve, allows for a number of treatment options prior to surgery, including drops and lasers, research has shown traditional surgical techniques could result in higher risks of vision complications, longer recovery times, and higher associated costs. Identifying this disconnect, Malik Y. Kahook, MD, professor of ophthalmology and the Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine, sought out a more accessible and practical solution to propel glaucoma treatment into the 21st century.
Rachel Wittel | January 31, 2022
Denver 7
May 24, 2022
Dr. Jayashree Kalpathy-Cramer discusses a recent study found that AI deep learning models can be trained to identify race in these same medical images. Something radiologists could only determine with 50 percent accuracy.
AAO Newsroom
May 10, 2022
Dr. Casey Smith discusses guidelines on using corneal tomography to screen for keratoconus in children with Down syndrome. Screening is recommended not only because keratoconus is prevalent in this population, but because those with Down syndrome may be less likely to be myopic and to have lower rates of astigmatism at the time of keratoconus than those without Down syndrome.
Neurodiem
May 03, 2022
Half of the human brain is devoted to vision, either exclusively or through important connections within functional networks essential for memory, cognition, and behavior. Not surprisingly, most people with a neurodegenerative disease that leads to dementia will develop higher-order visual dysfunction at some point in the course of their illness, including the pre-dementia or mild cognitive impairment stage.
Glaucoma Today
April 30, 2022
Given that much clinical decision-making in glaucoma is based on IOP, it seems surprising that, on average, providers rely on a handful of in-office IOP measurements obtained over the course of a year to determine IOP control. Monica K. Ertel, MD, and Leonard K. Seibold, MD, discuss the use of the iCare Home to improve clinical decision-making.
